Today, sixty-six members of Congress representing both Republicans and Democrats sent a letter to Speaker Ryan, Senate Majority Leader McConnell, Leader Pelosi, and Leader Schumer urging them to maintain the federal protections for the 46 states that have implemented some form of medical cannabis programs throughout the country.
Month: November 2017
On Tuesday, travel radio and television host Rick Steves, a NORML Board Member, journeyed to Illinois to testify in support of marijuana legalization effort in the state legislature.
We’ve made so much progress over the last year, all thanks to you. But there is still so much to be done. We expect 2018 to be even more successful for the movement, and we need you to help continue our momentum by making a contribution in honor of #GivingTuesday. Now more than ever is when we need your support to ensure that we achieve a fair legalization and equitable marijuana market.
Members of the Canadian House of Commons voted 200 to 82 to approve legislation that seeks to legalize and regulate the adult use cannabis market. Proponents of the legislation hope to have the new law in place by July 1, 2018.
One of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media. Since the mainstream media seldom casts a critical eye toward many of the more over-the-top claims about cannabis, we take it upon ourselves to set the record straight.
We have much to be thankful for this year. Lawmakers in 26 states have passed legislation to advance cannabis reform, including New Hampshire becoming the 22nd state to decriminalize marijuana and West Virginia becoming the 30th state to pass a medical marijuana program.
Proponents of a Michigan voter initiative effort to legalize and regulate the personal use and retail sale of cannabis today turned in more than 360,000 signatures in an effort to qualify the measure for the November 2018 ballot.
Chronic pain patients enrolled in a statewide medical cannabis access program are significantly more likely to either reduce or cease their use of opioids as compared to non-enrolled patients suffering from similar pain conditions, according to data published online in the journal PLOS One.
